# Abbott Laboratories: filings

ABT · NYSE · CIK 1800 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abt.md) · [Financials](/companies/abt/financials.md) · [Filings](/companies/abt/filings.md) · [Insiders](/companies/abt/insiders.md)

## Reports and events: 321 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1862, 8-K 212, 3 74, 10-Q 53, 144 49, CORRESP 37, UPLOAD 35, SC 13G/A 31, 425 24, 4/A 24, 10-K 18, 11-K 18, DEF 14A 18, NO ACT 16, S-8 15, SC TO-T/A 14, SD 13, DEFA14A 11, ARS 9, 424B5 8, 8-K/A 8, PX14A6G 7, SC 13D/A 7, SC 13G 7, 424B3 6, FWP 6, S-3ASR 6, SC TO-C 6, 3/A 4, S-4/A 4, SC 13D 4, D 3, S-8 POS 3, SC TO-T 3, EFFECT 2, S-4 2, SCHEDULE 13G/A 2, 10-K/A 1, 5 1, PRE 14A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 13:19 ET | [8-K](/filings/0001104659-26-117587.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117587 |
| 2026-10-21 | 11:36 ET | [8-K](/filings/0001628280-26-066601.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-066601 |
| 2026-08-20 | 20:33 ET | [8-K](/filings/0001104659-26-099247.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-099247 |
| 2026-07-28 | 20:02 ET | [10-Q](/filings/0001628280-26-050134.md) | Quarterly report, period 2026-06-30 | 0001628280-26-050134 |
| 2026-07-16 | 11:36 ET | [8-K](/filings/0001628280-26-048377.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-048377 |
| 2026-04-29 | 20:05 ET | [10-Q](/filings/0001628280-26-028357.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028357 |
| 2026-04-27 | 20:06 ET | [8-K](/filings/0001104659-26-049434.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-049434 |
| 2026-04-17 | 20:04 ET | [8-K](/filings/0001104659-26-044892.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-044892 |
| 2026-04-16 | 11:36 ET | [8-K](/filings/0001628280-26-025365.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-025365 |
| 2026-03-23 | 12:54 ET | [8-K](/filings/0001104659-26-033079.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-033079 |
| 2026-03-13 | 20:00 ET | [DEF 14A](/filings/0001308179-26-000064.md) | Proxy statement, period 2026-04-24 | 0001308179-26-000064 |
| 2026-03-09 | 20:21 ET | [8-K](/filings/0001104659-26-025240.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-025240 |
| 2026-02-26 | 21:16 ET | [8-K](/filings/0001104659-26-020509.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-020509 |
| 2026-02-20 | 21:17 ET | [8-K](/filings/0001104659-26-018167.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-018167 |
| 2026-02-20 | 21:05 ET | [10-K](/filings/0001628280-26-010185.md) | Annual report, period 2025-12-31 | 0001628280-26-010185 |
| 2026-01-22 | 12:35 ET | [8-K](/filings/0001628280-26-002982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-002982 |
| 2025-12-12 | 21:10 ET | [8-K](/filings/0001104659-25-120657.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-120657 |
| 2025-11-21 | 21:06 ET | [8-K](/filings/0001104659-25-114995.md) | 5.04 Item not in the standard list; 9.01 Financial statements and exhibits | 0001104659-25-114995 |
| 2025-11-20 | 12:37 ET | [8-K](/filings/0001104659-25-114422.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-114422 |
| 2025-10-29 | 20:22 ET | [10-Q](/filings/0001628280-25-047131.md) | Quarterly report, period 2025-09-30 | 0001628280-25-047131 |
| 2025-10-15 | 11:33 ET | [8-K](/filings/0001628280-25-045049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-045049 |
| 2025-07-30 | 20:14 ET | [10-Q](/filings/0001628280-25-036720.md) | Quarterly report, period 2025-06-30 | 0001628280-25-036720 |
| 2025-07-17 | 11:34 ET | [8-K](/filings/0001628280-25-035135.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-035135 |
| 2025-05-01 | 20:01 ET | [8-K](/filings/0001104659-25-043508.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-043508 |
| 2025-04-30 | 20:14 ET | [10-Q](/filings/0001628280-25-021090.md) | Quarterly report, period 2025-03-31 | 0001628280-25-021090 |
| 2025-04-28 | 20:10 ET | [8-K](/filings/0001104659-25-040201.md) | 5.07 Shareholder vote results | 0001104659-25-040201 |
| 2025-04-16 | 11:36 ET | [8-K](/filings/0001628280-25-017924.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-017924 |
| 2025-03-14 | 20:07 ET | [DEF 14A](/filings/0001308179-25-000134.md) | Proxy statement, period 2025-04-25 | 0001308179-25-000134 |
| 2025-02-21 | 21:07 ET | [10-K](/filings/0001628280-25-007110.md) | Annual report, period 2024-12-31 | 0001628280-25-007110 |
| 2025-01-22 | 12:13 ET | [8-K](/filings/0001628280-25-002092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-002092 |
| 2024-11-15 | 21:13 ET | [8-K](/filings/0001104659-24-119717.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-119717 |
| 2024-10-31 | 21:14 ET | [10-Q](/filings/0001628280-24-044602.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044602 |
| 2024-10-16 | 11:37 ET | [8-K](/filings/0001628280-24-042893.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-042893 |
| 2024-07-31 | 20:02 ET | [10-Q](/filings/0001628280-24-033740.md) | Quarterly report, period 2024-06-30 | 0001628280-24-033740 |
| 2024-07-18 | 11:37 ET | [8-K](/filings/0001628280-24-032182.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-032182 |
| 2024-05-02 | 20:11 ET | [10-Q](/filings/0001628280-24-020011.md) | Quarterly report, period 2024-03-31 | 0001628280-24-020011 |
| 2024-05-01 | 20:02 ET | [8-K](/filings/0001104659-24-055724.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-055724 |
| 2024-04-29 | 20:08 ET | [8-K](/filings/0001104659-24-054016.md) | 5.07 Shareholder vote results | 0001104659-24-054016 |
| 2024-04-17 | 11:36 ET | [8-K](/filings/0001628280-24-016497.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-016497 |
| 2024-03-15 | 20:03 ET | [DEF 14A](/filings/0001308179-24-000182.md) | Proxy statement, period 2024-04-26 | 0001308179-24-000182 |
| 2024-02-16 | 21:15 ET | [10-K](/filings/0001628280-24-005348.md) | Annual report, period 2023-12-31 | 0001628280-24-005348 |
| 2024-01-29 | 21:10 ET | [8-K](/filings/0001104659-24-007725.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001104659-24-007725 |
| 2024-01-24 | 12:36 ET | [8-K](/filings/0001628280-24-002009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-002009 |
| 2023-11-01 | 20:07 ET | [10-Q](/filings/0001628280-23-035957.md) | Quarterly report, period 2023-09-30 | 0001628280-23-035957 |
| 2023-10-18 | 11:37 ET | [8-K](/filings/0001628280-23-034544.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-034544 |
| 2023-09-01 | 20:13 ET | [8-K/A](/filings/0001104659-23-097759.md) | 5.07 Shareholder vote results | 0001104659-23-097759 |
| 2023-08-03 | 20:07 ET | [10-Q](/filings/0001628280-23-027203.md) | Quarterly report, period 2023-06-30 | 0001628280-23-027203 |
| 2023-07-20 | 12:29 ET | [8-K](/filings/0001628280-23-025156.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-025156 |
| 2023-06-12 | 14:32 ET | [8-K](/filings/0001104659-23-070203.md) | 5.02 Departure or appointment of officers or directors | 0001104659-23-070203 |
| 2023-06-09 | 20:05 ET | [8-K/A](/filings/0001104659-23-069894.md) | 5.07 Shareholder vote results | 0001104659-23-069894 |

Page 1 of 7. [Older](/companies/abt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:50 ET. No prices; not investment advice.